These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7621843)
1. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group. Gunn SD; Ayres JG; McConchie SM Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843 [TBL] [Abstract][Full Text] [Related]
2. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group. Wallaert B; Brun P; Ostinelli J; Murciano D; Champel F; Blaive B; Montané F; Godard P Respir Med; 1999 Jan; 93(1):33-8. PubMed ID: 10464846 [TBL] [Abstract][Full Text] [Related]
3. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441 [TBL] [Abstract][Full Text] [Related]
5. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group. Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040 [TBL] [Abstract][Full Text] [Related]
6. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients. Persson G; Baas A; Knight A; Larsen B; Olsson H Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191 [TBL] [Abstract][Full Text] [Related]
8. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects. Midgren B; Melander B; Persson G Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219 [TBL] [Abstract][Full Text] [Related]
9. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769 [TBL] [Abstract][Full Text] [Related]
10. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
11. Bambuterol: effects of a new anti-asthmatic drug. Pedersen BK; Laursen LC; Gnosspelius Y; Faurschou P; Weeke B Eur J Clin Pharmacol; 1985; 29(4):425-7. PubMed ID: 3912186 [TBL] [Abstract][Full Text] [Related]
12. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group. Brambilla C; Chastang C; Georges D; Bertin L Allergy; 1994 Jul; 49(6):421-6. PubMed ID: 7915501 [TBL] [Abstract][Full Text] [Related]
13. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily. Persson G; Gnosspelius Y; Anehus S Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075 [TBL] [Abstract][Full Text] [Related]
14. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group. Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma. Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653 [TBL] [Abstract][Full Text] [Related]
16. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma. Wempe JB; Tammeling EP; Postma DS; Auffarth B; Teengs JP; Koëter GH J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):349-57. PubMed ID: 1356117 [TBL] [Abstract][Full Text] [Related]
17. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study. Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206 [TBL] [Abstract][Full Text] [Related]
18. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists. Rosenburg J Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578 [TBL] [Abstract][Full Text] [Related]
19. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma. Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. Scalabrin DM; Solé D; Naspitz CK J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]